|
G |
Ache |
acetylcholinesterase |
decreases activity multiple interactions decreases expression affects activity |
ISO EXP |
Dimethoate results in decreased activity of ACHE protein pralidoxime inhibits the reaction [Dimethoate results in decreased activity of ACHE protein] Acetylcysteine inhibits the reaction [Dimethoate results in decreased activity of ACHE protein] Dimethoate results in decreased expression of ACHE protein Dimethoate affects the activity of ACHE protein |
CTD |
PMID:3247000 PMID:15033006 PMID:16112538 PMID:16112789 PMID:16701032 PMID:16833148 PMID:17997881 PMID:18070496 PMID:19793545 PMID:19917271 PMID:25082528 PMID:25967365 PMID:26482405 PMID:26769589 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
decreases phosphorylation |
ISO |
Dimethoate results in decreased phosphorylation of AKT2 protein |
CTD |
PMID:23994500 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
increases response to substance multiple interactions |
ISO |
ALB protein results in increased susceptibility to Dimethoate ALB protein promotes the reaction [Zinc Oxide binds to Dimethoate] |
CTD |
PMID:27441385 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
multiple interactions |
ISO |
[Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in decreased expression of ALDH2 mRNA; [Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in decreased expression of and results in decreased activity of ALDH2 protein |
CTD |
PMID:34830855 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
Dimethoate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] |
CTD |
PMID:29149346 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
ISO EXP |
Dimethoate results in decreased activity of BCHE protein |
CTD |
PMID:19793545 PMID:24052565 PMID:26482405 PMID:27441385 PMID:30243730 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Cat |
catalase |
multiple interactions increases expression increases activity decreases activity |
EXP ISO |
[Dimethoate co-treated with Malathion] results in increased activity of CAT protein; [Phorate co-treated with acephate co-treated with Dichlorvos co-treated with Dimethoate] results in decreased activity of CAT protein; Acetylcysteine inhibits the reaction [Dimethoate results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein] Dimethoate results in increased expression of CAT protein Ascorbic Acid inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein] |
CTD |
PMID:11834209 PMID:16112789 PMID:20077558 PMID:22034174 PMID:26482405 PMID:26769589 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Dimethoate results in increased expression of CCL2 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
Dimethoate results in increased expression of CD86 protein |
CTD |
PMID:23994500 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
decreases expression |
EXP |
Dimethoate results in decreased expression of CHRM1 mRNA; Dimethoate results in decreased expression of CHRM1 protein |
CTD |
PMID:14694657 PMID:15033006 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
decreases expression |
EXP |
Dimethoate results in decreased expression of CHRM2 mRNA; Dimethoate results in decreased expression of CHRM2 protein |
CTD |
PMID:14694657 PMID:15033006 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
increases expression decreases expression |
ISO EXP |
Dimethoate results in increased expression of CHRM3 mRNA Dimethoate results in decreased expression of CHRM3 mRNA |
CTD |
PMID:15033005 PMID:15033006 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Cnst |
consortin, connexin sorting protein |
increases expression |
ISO |
Dimethoate results in increased expression of CNST mRNA |
CTD |
PMID:23397585 |
|
NCBI chr13:91,296,740...91,373,531
Ensembl chr13:91,296,142...91,373,531
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression multiple interactions |
ISO |
Dimethoate results in increased expression of CXCL10 mRNA Estradiol inhibits the reaction [Dimethoate results in increased expression of CXCL10 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Dimethoate results in increased expression of CXCL10 mRNA]] |
CTD |
PMID:23943137 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases activity multiple interactions decreases expression |
ISO EXP |
Dimethoate results in decreased activity of CYP11A1 protein Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:11054639 PMID:26769589 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
Dimethoate results in increased expression of CYP19A1 mRNA |
CTD |
PMID:23943137 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2d1 |
cytochrome P450, family 2, subfamily d, polypeptide 1 |
increases expression |
EXP |
Dimethoate results in increased expression of CYP2D1 mRNA |
CTD |
PMID:25967365 |
|
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases activity increases expression |
ISO |
Dimethoate results in decreased activity of ESR1 protein Dimethoate results in increased expression of ESR1 protein |
CTD |
PMID:22562034 PMID:23943137 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
ISO |
Dimethoate results in increased expression of ESR2 mRNA |
CTD |
PMID:23943137 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression |
EXP |
Dimethoate results in increased expression of FSHB protein |
CTD |
PMID:19579042 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity |
EXP |
Dimethoate results in increased activity of G6PDX protein |
CTD |
PMID:16112789 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
Dimethoate results in increased expression of GFAP mRNA; Dimethoate results in increased expression of GFAP protein |
CTD |
PMID:21941777 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
EXP |
Dimethoate results in increased expression of GSR protein |
CTD |
PMID:16112789 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
increases expression |
ISO |
Dimethoate results in increased expression of GULP1 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
[Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in increased expression of H2AX protein |
CTD |
PMID:34830855 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:26769589 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b3 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of HSD3B3 mRNA] |
CTD |
PMID:26769589 |
|
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:186,138,044...186,144,033
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
ISO |
Dimethoate results in decreased expression of ID3 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Il10 |
interleukin 10 |
decreases secretion |
ISO |
Dimethoate results in decreased secretion of IL10 protein |
CTD |
PMID:23994500 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
increases secretion increases expression multiple interactions |
ISO |
Dimethoate results in increased secretion of IL1B protein Dimethoate results in increased expression of IL1B mRNA Estradiol inhibits the reaction [Dimethoate results in increased expression of IL1B mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Dimethoate results in increased expression of IL1B mRNA]] |
CTD |
PMID:23943137 PMID:23994500 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
Dimethoate affects the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Estradiol inhibits the reaction [Dimethoate results in increased expression of IL6 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Dimethoate results in increased expression of IL6 mRNA]] |
CTD |
PMID:23891859 PMID:23943137 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Klf9 |
KLF transcription factor 9 |
increases expression |
ISO |
Dimethoate results in increased expression of KLF9 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
decreases activity |
EXP |
Dimethoate results in decreased activity of KMO protein |
CTD |
PMID:2119399 |
|
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
decreases activity |
EXP |
Dimethoate results in decreased activity of KYAT1 protein |
CTD |
PMID:2119399 |
|
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression multiple interactions increases expression |
ISO EXP |
Dimethoate results in decreased expression of LHB protein rofecoxib inhibits the reaction [Dimethoate results in increased expression of LHB protein] |
CTD |
PMID:19579042 PMID:19726577 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
Dimethoate results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:23994500 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
ISO |
Dimethoate inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Dimethoate inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] |
CTD |
PMID:29149346 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Pdxk |
pyridoxal kinase |
decreases activity |
EXP ISO |
Dimethoate results in decreased activity of PDXK protein |
CTD |
PMID:2119399 PMID:2547861 |
|
NCBI chr20:10,210,276...10,232,314
Ensembl chr20:10,210,289...10,232,110
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
EXP |
Dimethoate results in increased expression of PTGS2 protein [Dimethoate co-treated with Eicosapentaenoic Acid] results in increased expression of PTGS2 protein; Docosahexaenoic Acids inhibits the reaction [Dimethoate results in increased expression of PTGS2 protein]; docosapentaenoic acid inhibits the reaction [Dimethoate results in increased expression of PTGS2 protein] |
CTD |
PMID:19579042 PMID:22476691 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
S100b |
S100 calcium binding protein B |
increases expression |
EXP |
Dimethoate results in increased expression of S100B mRNA; Dimethoate results in increased expression of S100B protein |
CTD |
PMID:21941777 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression increases expression multiple interactions |
ISO EXP |
Dimethoate results in decreased expression of STAR mRNA Dimethoate results in increased expression of STAR mRNA Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of STAR mRNA]; Arachidonic Acid inhibits the reaction [Dimethoate results in decreased expression of STAR protein]; Eicosapentaenoic Acid promotes the reaction [Dimethoate results in decreased expression of STAR protein] Dimethoate results in decreased expression of STAR mRNA; Dimethoate results in decreased expression of STAR protein |
CTD |
PMID:11054639 PMID:19579042 PMID:22476691 PMID:23943137 PMID:26769589 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tbx3 |
T-box transcription factor 3 |
increases expression |
ISO |
Dimethoate results in increased expression of TBX3 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
decreases activity |
ISO |
Dimethoate results in decreased activity of TDO2 protein |
CTD |
PMID:2547861 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tgoln2 |
trans-golgi network protein 2 |
increases expression |
ISO |
Dimethoate results in increased expression of TGOLN2 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
Dimethoate results in increased expression of TNF mRNA Estradiol inhibits the reaction [Dimethoate results in increased expression of TNF mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Dimethoate results in increased expression of TNF mRNA]] |
CTD |
PMID:23891859 PMID:23943137 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|